Clinical Trial

The Assessment of Infrared Treatment for Crohn's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test the safety and efficacy of far Infra-red (fIR) therapy in Crohn's disease patients. The main questions it aims to answer are: 1. Is infrared therapy safe for treating Crohn's disease patients? 2. Is infrared therapy effective for treating Crohn's disease? Participants will be asked to attend 10 treatments of fIR therapy, provide stool and blood samples and answer questionnaires. Researchers will compare between 4 treatments: three intensities of fIR therapy and placebo treatment to explore which intensity is most effective for treating Crohn's disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-19; most recent amendment 2026-02-22.
Trial Details
NCT Number NCT06146816
Lead Sponsor Shmuel Kivity, MD
Conditions IBD, Inflammatory Bowel Diseases, Crohn Disease
Enrollment 40 participants
Start Date 2023-09-12
Primary Completion 2027-09 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-24